| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2001.19.2.488 |
| P698 | PubMed publication ID | 11208843 |
| P2093 | author name string | A Rey | |
| B Sandstedt | |||
| C Com-Nougué | |||
| International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee | |||
| J de Kraker | |||
| J Godzinski | |||
| J M Burgers | |||
| J M Zucker | |||
| M Carli | |||
| M F Tournade | |||
| R Ludwig | |||
| R Potter | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 488-500 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study | |
| P478 | volume | 19 |
| Q53241945 | A Retrospective Study of the Preoperative Treatment of Advanced Wilms Tumor in Children with Chemotherapy versus Transcatheter Arterial Chemoembolization Alone or Combined with Short-term Systemic Chemotherapy |
| Q91909572 | Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia |
| Q51945038 | Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor |
| Q37546050 | Bilateral Wilms' tumor: the need to improve outcomes |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q37400822 | Central pathology review in multicenter trials and studies: lessons from the nephroblastoma trials |
| Q45904031 | Challenges for paediatric oncology in Africa. |
| Q48143317 | Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion |
| Q101220913 | Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience |
| Q47670734 | Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric O |
| Q35571401 | Complications in pediatric surgical oncology |
| Q36586126 | Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary Nodules |
| Q40811848 | Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney |
| Q34794743 | Controversies and advances in the management of Wilms' tumour |
| Q37738817 | Current management of wilms' tumor |
| Q52947831 | Cytogenetic findings and clinical course in a consecutive series of Wilms tumors |
| Q36806598 | Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer. |
| Q38112088 | Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria |
| Q35862100 | Efficacy of Preoperative Chemotherapy in Treatment of Children With Wilms' Tumor: A Meta-Analysis |
| Q42274969 | Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors |
| Q39349862 | Gain of 1q is a marker of poor prognosis in Wilms' tumors |
| Q34190897 | Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse |
| Q30475964 | Glomerular filtration rate and prevalence of chronic kidney disease in Wilms' tumour survivors. |
| Q49569330 | HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients. |
| Q44245121 | High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma |
| Q43785491 | Incidence and outcomes of patients with late recurrence of Wilms' tumor |
| Q90664454 | Investigating Wilms' Tumours Worldwide: A Report of the OxPLORE Collaboration-A Cross-Sectional Observational Study |
| Q48158202 | Is Pre-operative Chemotherapy Desirable in all Patients of Wilms' Tumor? |
| Q99405671 | Is it always Wilms' tumor? Localized cystic disease of the kidney in an infant: An extremely rare case report and review of the literature |
| Q44757176 | Long-term Follow-up of Infantile Wilms Tumor Treated According to International Society of Pediatric Oncology Protocol: Seven Years' Follow-up |
| Q33819087 | Malignant tumours of the kidney: imaging strategy |
| Q62493925 | Management of Children With a Wilms Tumor in Malawi, Sub-Saharan Africa |
| Q37287143 | Management of Wilms tumor: current standard of care |
| Q35618789 | Management of Wilms' tumour: current practice and future goals |
| Q63722756 | Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in wilms tumor |
| Q54547476 | New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors |
| Q40295566 | Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial |
| Q35141877 | Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy |
| Q36926456 | Part II: Treatment of primary malignant non-Wilms' renal tumours in children |
| Q58571045 | Pediatric Solid Tumors in Resource-Constrained Settings: A Review of Available Evidence on Management, Outcomes, and Barriers to Care |
| Q48564189 | Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol |
| Q50421735 | Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol |
| Q34622006 | Post‐transplant lymphoproliferative disorder resembling Wilms tumor. Diagnostic dilemma: Renal biopsy or nephrectomy? |
| Q52964196 | Predictive factor for intraoperative tumor rupture of Wilms tumor. |
| Q53216199 | Preoperative Wilms tumor rupture: a retrospective study of 57 patients |
| Q35574604 | Pre‐ or post‐operative treatment for sWilms tumor? who, what, when, where, how, why—and which |
| Q44813146 | Prognosis of Wilm's tumor in the course of the SIOP trials and studies |
| Q34700489 | Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4 |
| Q45089277 | Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial |
| Q37193391 | Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour |
| Q38630842 | Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group |
| Q95852637 | Results of treatment for patients with multicentric or bilaterally predisposed unilateral Wilms tumor (AREN0534): A report from the Children's Oncology Group |
| Q43413833 | SIOP PODC: clinical guidelines for the management of children with Wilms tumour in a low income setting |
| Q57339632 | Secondary Neoplasms After Wilms’ Tumor in Germany |
| Q33886717 | Secondary malignant neoplasms after Wilms tumor: an international collaborative study. |
| Q74690909 | Streptococcus mitis-infected nephroblastoma. An unusual fine-needle aspiration diagnosis |
| Q80899077 | Success of clinical trials in childhood Wilms' tumour around the world |
| Q43822717 | Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). |
| Q36683015 | Synovial sarcoma of kidney in a child: A rare presentation |
| Q28083371 | The current status of treatment of Wilms' tumor as per the SIOP trials |
| Q46725044 | The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour |
| Q36983667 | The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group |
| Q37579145 | Therapeutic results in stage I Wilms' tumors in children - 15 years of surgical experience |
| Q35770478 | Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression. |
| Q93121850 | Treatment of Wilms Tumor in Sub-Saharan Africa: Results of the Second French African Pediatric Oncology Group Study |
| Q84785824 | Treatment of nephroblastoma in Africa: Results of the first French African pediatric oncology group (GFAOP) study |
| Q51837873 | Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only |
| Q98906876 | Wilms tumor in patients with osteopathia striata with cranial sclerosis |
| Q36130424 | Wilms tumor: what's new? |
| Q37008428 | Wilms tumour: prognostic factors, staging, therapy and late effects |
| Q37291173 | Wilms' tumor: An update |
| Q57339663 | Wilms-Tumor bei Erwachsenen |
| Q81563891 | [Benign epithelial cells and Tamm-Horsfall protein in lymph nodes from nephrectomy specimens with nephroblastoma: a diagnostic pitfall] |
| Q78603160 | [Pseudotumoral diseases: ten years of experience in a pediatric oncology department] |
| Q35679310 | β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors |
Search more.